PSYCHOACTIVE cover image

Daniel Wolfe on Funding Global Harm Reduction

PSYCHOACTIVE

00:00

Global Use of Buprenorphine and Methadone for Harm Reduction

This chapter explores the regulations and policies surrounding the use of buprenorphine and methadone for harm reduction in opioid addiction worldwide. It emphasizes the need for a diverse range of treatment options and the importance of patient perspectives.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app